查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828202

2025年頭頸癌診斷全球市場報告

Head And Neck Cancer Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，頭頸癌診斷市場規模迅速擴張，從2024年的17.4億美元成長到2025年的20.3億美元，複合年成長率為16.6%。預測期內的成長可歸因於菸草和酒精消費的增加、人口老化、意識提升宣傳活動、切片檢查技術的發展以及醫療基礎設施的改善等因素。

預計未來幾年頭頸癌診斷市場將快速成長，到2029年將達到38.3億美元，複合年成長率為17.2%。預測期內的成長可歸因於基因生物標記、HPV相關癌症盛行率的上升、人工智慧(AI)、免疫療法和標靶治療的整合，以及醫療保健政策和報銷的變化。預測期內的全球趨勢包括液態切片的主導地位、多重模式診斷、照護現場診斷、全球合作夥伴關係以及數位病理學的整合。

頭頸癌的診斷需要結合多種方法，包括身體檢查、影像檢查、病歷評估和組織切片檢查，以識別和確認頭頸部的惡性細胞。此診斷程序常用於鱗狀細胞癌、喉癌和下嚥癌的治療。

頭頸癌診斷的主要方法包括影像設備、內視鏡設備、切片檢查篩檢和牙科診斷。影像設備包括各種醫療工具，用於產生用於診斷的內臟器官和組織影像。這些診斷過程涉及多個管道，包括零售藥局、專科藥局、醫院藥局和線上藥局。受益於這些診斷方法的最終用戶包括醫院、診斷中心等。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供頭頸癌診斷市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的頭頸癌診斷細分市場、市場趨勢和機遇，以及您在頭頸癌診斷行業取得成功所需的數據。本頭頸癌診斷市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為17.2%，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接影響美國，導致來自法國和荷蘭等主要地區的窄頻成像內視鏡和分子生物標記檢測套組的供應鏈中斷，從而導致癌症檢測延遲和病理學服務成本上升。此外，這種影響可能會透過互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易造成的負面影響，在更廣泛的範圍內顯現。

預計頭頸癌診斷市場的未來成長將受到頭頸癌發病率上升的推動。這類腫瘤會影響頭部和頸部的各種組織和器官，包括口腔、咽喉、唾液腺、鼻腔和副鼻竇。頭頸癌診斷透過切開切片檢查和鋇餐吞嚥研究等測試在早期發現疾病方面發揮關鍵作用。例如，2023 年 2 月，美國臨床腫瘤學會報告稱，頭頸癌將占美國所有惡性腫瘤的 4%，預計 2023 年將有 66,920 例病例。包括澳洲在內，全球發病率的上升是頭頸癌診斷市場成長的主要驅動力，2022 年將出現 5,189 例新患者。

個人化醫療的日益普及預計將促進頭頸癌診斷市場的成長。個人化醫療是指根據每位患者的個別情況制定個人化治療方案，以最佳化治療效果並最大程度地減少副作用。精準影像和個人化追蹤護理對於有效管理頭頸癌至關重要。 2022年，美國食品藥物管理局(FDA) 藥品評估與研究中心 (CDER)核准了37個新分子實體 (NME)，其中約34%（相當於12個NME）被個人化醫療聯盟 (PMC) 歸類為個人化醫療。個人化醫療的普及反映了推動頭頸癌診斷市場成長的關鍵趨勢。

產品創新是頭頸癌診斷市場的突出趨勢，領先公司專注於開發創新產品以鞏固其市場地位。例如，2023 年 5 月，印度醫療保健公司 Alkem Laboratories Ltd. 推出了全球首個用於治療頭頸癌的生物相似藥 Cetuxa。 Cetuxa 是西妥昔單抗的生物相似藥，西Cetuximab昔單抗是一種具有抗腫瘤特性的單株抗體，可抑制受體依賴性訊號路徑。它與表皮生長因子受體 (EGFR) 的胞外結構域結合。在臨床實踐中，Cetuximab通常與化療和/或放射線治療結合，用於治療局部進行性、復發性和轉移性頭頸部鱗狀細胞癌。

頭頸癌診斷市場由提供牙科全景X光片、磁振造影(MRI) 和電腦斷層掃描 (CT) 掃描的營業單位所獲得的收益所構成。市場規模還包括服務提供者銷售或包含在其服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球頭頸癌診斷：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球頭頸癌診斷市場：成長率分析
  • 全球頭頸癌診斷市場表現：規模與成長，2019-2024
  • 全球頭頸癌診斷市場預測：規模與成長，2024-2029，2034
  • 全球頭頸癌診斷：總目標市場（TAM）

第6章 市場細分

  • 全球頭頸癌診斷市場（依診斷方法、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 診斷影像設備
  • 內視鏡設備
  • 切片檢查篩檢測試
  • 牙科診斷
  • 其他
  • 全球頭頸癌診斷市場（按通路、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 零售和專業藥局
  • 醫院藥房
  • 網路藥局
  • 全球頭頸癌診斷市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 其他
  • 全球頭頸癌診斷市場：診斷影像設備細分、類型、效能及預測（2019-2024、2024-2029、2034）
  • 電腦斷層掃描（CT）
  • 磁振造影（MRI）
  • 正子斷層掃描（PET）
  • X光
  • 全球頭頸癌診斷市場：內視鏡設備細分，按類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 硬內視鏡
  • 軟性內視鏡
  • 影像內視鏡系統
  • 全球頭頸癌診斷市場：切片檢查篩檢測試細分、類型、績效及預測（2019-2024、2024-2029、2034）
  • 細針抽吸切片檢查（FNA）
  • 芯針切片
  • 手術切片檢查
  • 全球頭頸癌診斷市場：牙科診斷細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 口內攝影機
  • 牙科X光相片
  • 口腔癌篩檢儀
  • 全球頭頸癌診斷市場：其他細分市場、按類型、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 分子診斷
  • 血液檢查
  • 基因檢測

第7章 區域和國家分析

  • 全球頭頸癌診斷市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球頭頸癌診斷市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 頭頸癌診斷市場：競爭格局
  • 頭頸癌診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Bristol Myers Squibb Co.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • BioNTech AG

第31章：其他領先和創新企業

  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Laboratory Corporation of America
  • Agilent Technologies Inc.
  • Hologic Inc.
  • Illumina Inc.
  • Shimadzu Corporation
  • Sysmex Corp.
  • Varian Medical Systems Inc.
  • QIAGEN NV
  • Exact Sciences Corp.
  • Bio-Techne Corp.
  • Carestream Health Inc.
  • Myriad Genetics Inc.
  • Cepheid Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年頭頸癌診斷市場：提供新機會的國家
  • 2029年頭頸癌診斷市場：細分市場帶來新機會
  • 2029年頭頸癌診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24988u

Head and neck cancer diagnostics involve the identification and confirmation of malignant cells in the head and neck region through a combination of methods, including physical examination, imaging tests, medical history assessment, and tissue biopsy. This diagnostic process is commonly applied in the treatment of squamous cell carcinomas, laryngeal cancer, and hypopharyngeal cancer.

The primary methods employed in head and neck cancer diagnostics include diagnostic imaging equipment, endoscopy screening equipment, biopsy screening tests, dental diagnostic methods, and others. Diagnostic imaging equipment comprises various medical tools utilized to generate images of the internal organs and tissues for diagnostic purposes. These diagnostic processes involve multiple channels, including retail and specialty pharmacies, hospital pharmacies, and online pharmacies. The end-users benefiting from these diagnostic methods encompass hospitals, diagnostic centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The head and neck cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides head and neck cancer diagnostics market statistics, including head and neck cancer diagnostics industry global market size, regional shares, competitors with a head and neck cancer diagnostics market share, detailed head and neck cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the head and neck cancer diagnostics industry. This head and neck cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The head and neck cancer diagnostics market size has grown rapidly in recent years. It will grow from $1.74 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to tobacco and alcohol consumption, increasing aging population, awareness campaigns, biopsy techniques development, healthcare infrastructure development.

The head and neck cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to genomic biomarkers, rising incidence of hpv-related cancers, integration of artificial intelligence (ai), immunotherapy and targeted therapies, healthcare policy and reimbursement changes. Major trends in the forecast period include liquid biopsy dominance, multi-modality diagnostics, point-of-care diagnostics, global collaborations and partnerships, digital pathology integration.

The forecast of 17.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for narrow-band imaging endoscopes and molecular biomarker test kits, sourced from key regions such as France and the Netherlands, which could lead to delayed cancer detection and increased pathology service costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth in the head and neck cancer diagnostics market in the future is expected to be driven by the increasing incidence of head and neck cancer. This group of tumors affects various tissues and organs in the head and neck region, including the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Head and neck cancer diagnostics play a crucial role in the early detection of the disease through tests such as incisional biopsy and barium swallow test. For example, in February 2023, the American Society of Clinical Oncology reported that head and neck cancer constituted 4% of all malignancies in the United States, with an estimated 66,920 people expected to be affected by it in 2023. This rise in incidence globally, such as in Australia, where there were 5,189 new cases in 2022, is a key driver for the growth of the head and neck cancer diagnostics market.

The increasing adoption of personalized medicines is expected to contribute to the growth of the head and neck cancer diagnostics market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, optimizing treatment outcomes, and minimizing side effects. Precision imaging and individualized follow-up care are crucial in managing head and neck cancers effectively. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), and approximately 34% of these, equivalent to 12 NMEs, were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This adoption of personalized medicine reflects a significant trend driving the growth of the head and neck cancer diagnostics market.

Product innovation is a prominent trend gaining traction in the head and neck cancer diagnostic market, with major players focusing on developing innovative products to strengthen their market position. For example, in May 2023, Alkem Laboratories Ltd., an India-based healthcare company, introduced Cetuxa, the world's first biosimilar for treating head and neck cancer. Cetuxa is a biosimilar to cetuximab, a monoclonal antibody with anti-tumor properties that inhibits the receptor-dependent transduction pathway. It binds to the extracellular domain of the epidermal growth factor receptor (EGFR). Clinical practice often combines cetuximab with chemotherapy or radiation therapy for treating locally advanced, recurring, or metastatic squamous cell carcinoma of the head and neck.

Major companies in the head and neck cancer diagnostics market are actively developing new products, such as antibodies, to gain a competitive advantage. Antibodies are proteins produced by the immune system in response to foreign substances. For instance, in February 2023, Roche Holding AG, a Switzerland-based pharmaceutical company, launched IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and ATRX Rabbit Polyclonal Antibody, offering advanced features in brain cancer diagnostics. These antibodies are specifically designed to detect mutations in the IDH1 and ATRX genes, providing clinicians with crucial diagnostic and prognostic information. The IDH1 antibody identifies the IDH1 R132H mutation in adult-type gliomas and acute myeloid leukemia (AML), aiding patient stratification for clinical trials. The ATRX antibody detects mutations in the ATRX gene, offering valuable insights for clinicians managing IDH-mutant gliomas.

In May 2022, Regeneron Pharmaceuticals Inc., a US-based pharmaceutical company, acquired Checkmate Pharmaceuticals Inc. for an undisclosed amount. This acquisition is expected to enhance Regeneron Pharmaceuticals' position as a leader in immuno-oncology and expand its strategic adaptability and innovation with promising monotherapy and combination candidates for challenging malignancies. Checkmate Pharmaceuticals Inc., a US-based biopharmaceutical company, focuses on discovering and developing cancer immunotherapy approaches, including immuno-oncology treatments for head and neck cancer.

Major companies operating in the head and neck cancer diagnostics market include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.

North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the head and neck cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The head and neck cancer diagnostic market consists of revenues earned by entities by providing panoramic dental X-ray, magnetic resonance imaging (MRI), and computerized tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Head And Neck Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on head and neck cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for head and neck cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The head and neck cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Method: Diagnostic Imaging Equipment; Endoscopy Screening Equipment; Biopsy Screening Tests; Dental Diagnostic Methods; Other Diagnostic Methods
  • 2) By Channel: Retail And Specialty Pharmacies; Hospital Pharmacies; Online Pharmacies
  • 3) By End-User: Hospitals; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans; X-rays
  • 2) By Endoscopy Screening Equipment: Rigid Endoscopes; Flexible Endoscopes; Video Endoscopy Systems
  • 3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy; Core Needle Biopsy; Surgical Biopsy
  • 4) By Dental Diagnostic Methods: Intraoral Cameras; Dental X-rays; Oral Cancer Screening Devices
  • 5) By Other Diagnostic Methods: Molecular Diagnostics; Blood Tests; Genetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bristol Myers Squibb Co.; Abbott Laboratories; Siemens Healthineers AG; BioNTech AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Laboratory Corporation of America; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.; Shimadzu Corporation; Sysmex Corp.; Varian Medical Systems Inc.; QIAGEN N.V.; Exact Sciences Corp.; Bio-Techne Corp.; Carestream Health Inc.; Myriad Genetics Inc.; Cepheid Inc.; Invitae Corporation; Accuray Inc.; Canon Medical Systems Corporation; NanoString Technologies Inc; Asuragen Inc.; Caris Life Sciences Inc.; HTG Molecular Diagnostics Inc.; Oncgnostics GmbH; Perseus Proteomics Inc.; VolitionRx Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Head And Neck Cancer Diagnostics Market Characteristics

3. Head And Neck Cancer Diagnostics Market Trends And Strategies

4. Head And Neck Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Head And Neck Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Head And Neck Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Head And Neck Cancer Diagnostics Market Growth Rate Analysis
  • 5.4. Global Head And Neck Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Head And Neck Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Head And Neck Cancer Diagnostics Total Addressable Market (TAM)

6. Head And Neck Cancer Diagnostics Market Segmentation

  • 6.1. Global Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Imaging Equipment
  • Endoscopy Screening Equipment
  • Biopsy Screening Tests
  • Dental Diagnostic Methods
  • Other Diagnostic Methods
  • 6.2. Global Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail And Specialty Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • 6.3. Global Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Other End Users
  • 6.4. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Diagnostic Imaging Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Computed Tomography (CT) Scans
  • Magnetic Resonance Imaging (MRI)
  • Positron Emission Tomography (PET) Scans
  • X-rays
  • 6.5. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Endoscopy Screening Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rigid Endoscopes
  • Flexible Endoscopes
  • Video Endoscopy Systems
  • 6.6. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Biopsy Screening Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fine Needle Aspiration (FNA) Biopsy
  • Core Needle Biopsy
  • Surgical Biopsy
  • 6.7. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Dental Diagnostic Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intraoral Cameras
  • Dental X-rays
  • Oral Cancer Screening Devices
  • 6.8. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Other Diagnostic Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Blood Tests
  • Genetic Testing

7. Head And Neck Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Head And Neck Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Head And Neck Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Head And Neck Cancer Diagnostics Market

  • 8.1. Asia-Pacific Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Head And Neck Cancer Diagnostics Market

  • 9.1. China Head And Neck Cancer Diagnostics Market Overview
  • 9.2. China Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Head And Neck Cancer Diagnostics Market

  • 10.1. India Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Head And Neck Cancer Diagnostics Market

  • 11.1. Japan Head And Neck Cancer Diagnostics Market Overview
  • 11.2. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Head And Neck Cancer Diagnostics Market

  • 12.1. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Head And Neck Cancer Diagnostics Market

  • 13.1. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Head And Neck Cancer Diagnostics Market

  • 14.1. South Korea Head And Neck Cancer Diagnostics Market Overview
  • 14.2. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Head And Neck Cancer Diagnostics Market

  • 15.1. Western Europe Head And Neck Cancer Diagnostics Market Overview
  • 15.2. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Head And Neck Cancer Diagnostics Market

  • 16.1. UK Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Head And Neck Cancer Diagnostics Market

  • 17.1. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Head And Neck Cancer Diagnostics Market

  • 18.1. France Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Head And Neck Cancer Diagnostics Market

  • 19.1. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Head And Neck Cancer Diagnostics Market

  • 20.1. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Head And Neck Cancer Diagnostics Market

  • 21.1. Eastern Europe Head And Neck Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Head And Neck Cancer Diagnostics Market

  • 22.1. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Head And Neck Cancer Diagnostics Market

  • 23.1. North America Head And Neck Cancer Diagnostics Market Overview
  • 23.2. North America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Head And Neck Cancer Diagnostics Market

  • 24.1. USA Head And Neck Cancer Diagnostics Market Overview
  • 24.2. USA Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Head And Neck Cancer Diagnostics Market

  • 25.1. Canada Head And Neck Cancer Diagnostics Market Overview
  • 25.2. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Head And Neck Cancer Diagnostics Market

  • 26.1. South America Head And Neck Cancer Diagnostics Market Overview
  • 26.2. South America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Head And Neck Cancer Diagnostics Market

  • 27.1. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Head And Neck Cancer Diagnostics Market

  • 28.1. Middle East Head And Neck Cancer Diagnostics Market Overview
  • 28.2. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Head And Neck Cancer Diagnostics Market

  • 29.1. Africa Head And Neck Cancer Diagnostics Market Overview
  • 29.2. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Head And Neck Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Head And Neck Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Head And Neck Cancer Diagnostics Market Competitive Landscape
  • 30.2. Head And Neck Cancer Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bristol Myers Squibb Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. BioNTech AG Overview, Products and Services, Strategy and Financial Analysis

31. Head And Neck Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Laboratory Corporation of America
  • 31.4. Agilent Technologies Inc.
  • 31.5. Hologic Inc.
  • 31.6. Illumina Inc.
  • 31.7. Shimadzu Corporation
  • 31.8. Sysmex Corp.
  • 31.9. Varian Medical Systems Inc.
  • 31.10. QIAGEN N.V.
  • 31.11. Exact Sciences Corp.
  • 31.12. Bio-Techne Corp.
  • 31.13. Carestream Health Inc.
  • 31.14. Myriad Genetics Inc.
  • 31.15. Cepheid Inc.

32. Global Head And Neck Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Head And Neck Cancer Diagnostics Market

34. Recent Developments In The Head And Neck Cancer Diagnostics Market

35. Head And Neck Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Head And Neck Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Head And Neck Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Head And Neck Cancer Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer